SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}- 4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor: I. Biochemical and Pharmacological Characterization-Reference-Cited by-同舟云学术

SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}- 4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor: I. Biochemical and Pharmacological Characterization

Published:2002-12-01 Issue:3 Volume:303 Page:1171-1179
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Emonds-Alt Xavier,Proietto Vincenzo,Steinberg Régis,Oury-Donat Florence,Vigé Xavier,Vilain Pol,Naline Emmanuel,Daoui Samira,Advenier Charles,Le Fur Gérard,Maffrand Jean-Pierre,Soubrié Philippe,Pascal Marc

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Tachykinin Receptor Antagonists and Cough

2. Antitussive effect of SR 48968, a non-peptide tachykinin NK2, receptor antagonist

3. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough

4. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors

5. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.;Beattie;Br J Pharmacol,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification;Organic Chemistry Frontiers;2022

2. Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules;Medicinal Research Reviews;2020-03

3. Asymmetric organocatalytic synthesis of tertiary azomethyl alcohols: key intermediates towards azoxy compounds and α-hydroxy-β-amino esters;Organic & Biomolecular Chemistry;2017

4. Retrieval and analysis of chemical substance and patent information to support creation and selection of nonproprietary names;Pharmaceutical Patent Analyst;2015-07

5. Preparation of chiral key intermediates of morpholine based neurokinin receptor antagonists by asymmetric allylic alkylation;Tetrahedron;2013-08